A prospective study of 115 initially asymptomatic HIV infected gay men in stockholm, sweden

References

• Cooper G S, Jeffers D J. The clinical prognosis of HIV‐1 infection: A review of 32 follow–up studies. J Gen Intern Med 1988; 3: 525–532
   PubMed Web of Science ®Google Scholar
• Pedersen C, Sandström E, Petersen C S, Norkrans G, Gerstoft J, Karlsson A, Christensen K C, Håkansson C, Person P, Nielsen J O, Jürgensen H J, TSIS Group. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. N Engl J Med 1990; 322: 1757–1763
   PubMed Web of Science ®Google Scholar
• Bratt G, von Krogh G, Moberg L, Karlsson A, Putkonen P ‐O, Biberfeld G, Böttiger M, Sandström E. Intradermal testing with multiple recall antigens for identification of cell‐mediated immune deficiency in homosexual men. Clin Immunol Immunopathol 1986; 41: 206–215
   PubMedGoogle Scholar
• Moss A R, Bacchetti P. Natural history of HIV infection AIDS 1989; 3: 55–61
   Google Scholar
• Goedert J J, Biggar R J, Weiss S H, Eyster M E, Melbye M, Wilson S, Ginzburg H M, Grossman R J, DiGiola R A, Sanchez W C, Giron J A, Ebbesen P, Gallo R C, Blattner W A. Three‐year incidence of AIDS in five cohorts of HTLV‐III‐infected risk group members. Science 1986; 231: 992–995
   PubMed Web of Science ®Google Scholar
• Wever J N, Rogers L A, Scott K, Berrie E, Harris J RW, Wadsworth J, Moshtael O, McManus T, Jeffries D J, Pinching A J. Three‐year prospective study of HTLV‐III infection in homosexual men. Lancet 1986; 1: 1179–1182
   PubMedGoogle Scholar
• Morfeldt‐Månson L. HIV infection. A prospective longitudinal study of clinical, immunological and virological characteristics of the infection. Thesis, Karolinska Institute, Roslagstull Hospital, StockholmSweden 1989
   Google Scholar
• Schechter M T, Craib K JP, Le T N, Willoughby B, Douglas B, Sestak P, Montaner J SG, Weaver M S, Elmslie K D, O'Shaughnessy M V. Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989; 3: 347–353
   PubMed Web of Science ®Google Scholar
• Hessol N A, Lifson A R, O'Malley P M, Doll L S, Jaffe H W, Rutherford G W. Prevalence, incidence and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978–1988. Am J Epidemiol 1989; 130: 1167–1175
   PubMed Web of Science ®Google Scholar
• Muñoz A, Wang M C, Bass S, Taylor J MG, Kingsley L A, Chmiel J S, Polk B F, The Multicenter AIDS Cohort Study Group. Acquired immunodeficiency syndrome (AIDS)‐free time after human immunodeficiency virus type 1 (HIV‐1) seroconversion in homosexual men. Am J Epidemiol 1989; 130: 530–539
   PubMed Web of Science ®Google Scholar
• Bacchetti P, Moss A R. Incubation period of AIDS in San Francisco. Nature 1989; 338: 251–253
   PubMed Web of Science ®Google Scholar
• Lui K J, Darrow W W, Rutherford G W, III. A model‐based estimate of the mean incubation period for AIDS in homosexual men. Science 1988; 240: 1333–1335
   PubMed Web of Science ®Google Scholar
• Von Krogh G, Broström C, Hermanson J, von Sydow M, Biberfeld G, Sandström E, Böttiger M. The introduction of HIV during 1979–80 in a sexually active homosexual population of Stockholm. Scand J Infect Dis 1987; 19: 285–288
   PubMedGoogle Scholar
• Mathur‐Wagh U, Mildvan D, Senie R T. Follow‐up at 4 1/2 years on homosexual men with generalized lymphadenopathy. N Engl J Med 1985; 313: 1542–1543
   PubMedGoogle Scholar
• Kaplan J, Spira T, Fishbein D, Bozeman M, Pinsky P, Schonberger L. A six‐year follow‐up of HIV‐infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. JAMA 1988; 260: 2694–2697
   PubMedGoogle Scholar
• Eyster M E, Gail M H, Ballard J O, Al‐Mondhiry H, Goedert J J. Natural history of human immunodeficiency virus infection in hemophiliacs: Effects of T‐cell subsets, platelet counts, and age. Ann Intern Med 1987; 107: 1–6
   PubMed Web of Science ®Google Scholar
• Giesecke J, Scalia‐Tomba G, Berglund O, Berntorp E, Schulman S, Stigendahl L. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br Med J 1988; 297: 99–102
   PubMedGoogle Scholar
• Ragni M V, Winkelstein A, Kingsley L, Spero J A, Lewis J H. 1986 update of HIV seroprevalence, seroconversion, AIDS incidence, and immunologic correlates of HIV infection in patients with hemophilia A and B. Blood 1987; 70: 786–790
   PubMed Web of Science ®Google Scholar
• Haverkos H W. Factors associated with the pathogenesis of AIDS. J Infect Dis 1987; 156: 251–257
   PubMedGoogle Scholar
• Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990; 4: 125–129
   PubMedGoogle Scholar
• Des Jarlais D C, Friedman S R, Marmor M, Cohen H, Mildvan D, Yancovitz S, Mathur U, El‐Sadr W, Spira T J, Garber J, Beatrice S T, Abdul‐Quader A S, Sotheran J L. Development of AIDS, HIV seroconversion, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1987; 1: 105–111
   PubMed Web of Science ®Google Scholar
• Goedert J J, Biggar R J, Melbye M, Mann D L, Wilson S, Gail M H, Grossman R J, DiGiola R A, Sanchez W C, Weiss S H, Blattner W A. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA 1987; 257: 331–334
   PubMed Web of Science ®Google Scholar
• Webster A, Lee C A, Cook D G, Grundy J E, Emery V C, Kernoff P BA, Giffiths P D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989; 2: 63–66
   PubMedGoogle Scholar
• Detels R, Visscher B R, Fahey J, Sever J L, Gravell M, Madden D L, Schwartz K, Dudley J P, English P A, Powers H, Clark V A, Gotlieb M. Predictors of clinical AIDS in young homosexual men in a high risk area. Int J Epidemiol 1987; 16: 271–276
   PubMedGoogle Scholar
• Jason J, Lui K J, Ragni M V, Hessol N A, Darrow W W. Risk of developing AIDS in HIV‐infected cohorts of hemophiliac and homosexual men. JAMA 1989; 261: 725–727
   PubMedGoogle Scholar
• Gail M H, Rosenberg P S, Goedert J J. Therapy may explain recent deficits in AIDS incidence. J AIDS 1990; 3: 296–306
   PubMed Web of Science ®Google Scholar
• Lifson A R, Darrow W W, Hessol N A, O'Malley P M, Barnhart J L, Jaffe H W, Rutherford G W. Kaposi's sarcoma in a cohort of homosexual and bisexual men. Am J Epidemiol 1990; 131: 221–231
   PubMed Web of Science ®Google Scholar
• Osmond D, Chaisson R, Moss A, Bacchetti P, Krampf W. Lymphadenopathy in asymptomatic patients seropositive for HIV. N Engl J Med 1987; 317: 246
   PubMed Web of Science ®Google Scholar
• Fauci A S, Macher A M, Longo D L, Lane H C, Rook A H, Masur H, Gelmann E P. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984; 100: 92–106
   PubMed Web of Science ®Google Scholar
• MacDonell K B, Chmiel J S, Goldsmith J A, Wallermark C ‐B, Steinberg J, Byers E, Phair J P. Prognostic usefulness of the Walter Reed staging classification for HIV infection. J AIDS 1988; 1: 367–374
   PubMedGoogle Scholar
• Monfardini S, Vaccher E, Pizzocaro G, Stellini R, Sinicco A, Sabbatani S, Marangolo M, Zagni R, Clerici M, Foà R, Tirelli U, Gavosto F. Unusual malignant tumours in 49 patients with HIV infection. AIDS 1989; 3: 449–452
   PubMed Web of Science ®Google Scholar
• Rivers J K, Kopf A W, Postel A H. Malignant melanoma in a man seropositive for the human immunodeficiency virus. J Am Acad Dermatol 1989; 20: 1127–1128
   PubMed Web of Science ®Google Scholar
• Kaplan M H, Susin M, Pahwa S G, Fetten J, Allen S L, Lichtman S, Sarngadharan M G, Gallo R C. Neoplastic complications of HTLV‐III infection. Lymphomas and solid tumors. Am J Med 1987; 82: 389–396
   PubMedGoogle Scholar